跳至主要内容
临床试验/ChiCTR2300068084
ChiCTR2300068084
尚未招募
不适用

Effects of stand-alone mindfulness practices for people with long COVID-19 symptoms: A randomized controlled trial

Health and Medical Research Fund, Food and Health Bureau, HKSAR1 个研究点 分布在 1 个国家开始时间: 2023年2月6日最近更新:

概览

阶段
不适用
状态
尚未招募
发起方
Health and Medical Research Fund, Food and Health Bureau, HKSAR
试验地点
1
主要终点
the self-report COVID-19 Yorkshire Rehabilitation Scale (C19-YRS)

概览

简要总结

This study aims to evaluate the effects of mindfulness practices as a standalone intervention (an 8-week 1.25-hour online mindfulness practices class led by a mindfulness teacher, together with practice audios and a self-help booklet) among people with long COVID-19 symptoms, comparing to a health education control through a randomized controlled trial design. The primary objective is to:

  1. Evaluate the effectiveness of the mindfulness practices in improving self-reported severity of long COVID-19 symptoms, functional disability, and overall health immediately after the 8-week intervention (primary time point) and 3 months after the intervention, comparing to the health education control. The secondary objectives are to:
  2. Evaluate the effectiveness of the mindfulness practices in reducing proportions of participants having 1+, 3+, and 5+ symptoms in the intervention group immediately and 3 months after the 8-week intervention, compared to the control.
  3. Evaluate the effectiveness of mindfulness practices in reducing depression, anxiety, health care utilization, and improving mindfulness and health-related quality of life immediately and 3 months after the intervention, compared to the control.

研究设计

研究类型
干预性研究
主要目的
随机平行对照
盲法
None

入排标准

年龄范围
18 至 100(—)
性别
All

入选标准

  • Aged 18 years or above,
  • With any self-reported long COVID-19 symptoms listed in the recent systematic review by Michelen and colleagues at least 3 months after tested positive for COVID-19, either through self-test or test in medical settings:
  • (1) Systematic symptoms (fatigue, weakness, general malaise, dizziness);
  • (2) Cardiopulmonary symptoms (breathlessness/dyspnoea, chest pain, cough, excessive sputum, others);
  • (3) Upper respiratory symptoms (voice change, sore throat, nasal congestion, others),
  • (4) Gastrointestinal symptoms (loss of appetite, stomach/abdominal discomfort/pain, weight loss, nausea or vomiting, diarrhoea, others);
  • (5) Musculoskeletal symptoms (muscle pain/myalgia, joint pain/arthralgia, impaired mobility, others);
  • (6) Neurological and neuromuscular symptoms (abnormal reflex status, smell disturbance, taste disturbance, decreased sensation or sensibility, tingling/ paraesthesia, others);
  • (7) Neurocognitive symptoms (memory impairment, concentration impairment, frontal release signs, others), or others (hair loss, skin rash etc.)
  • No regular practice of mindfulness meditation.

排除标准

  • Diagnosed psychiatric disorders, and suicidal ideation, plans, or behaviours, as they may need more intensive clinical care;
  • Recent bereavement or major loss;
  • Cannot understand Chinese as the programs will be conducted in Chinese;
  • Other conditions render them incapable of following the interventions.

研究组 & 干预措施

Intervention group

Control group

结局指标

主要结局

the self-report COVID-19 Yorkshire Rehabilitation Scale (C19-YRS)

时间窗: At baseline, 2 months (immediately after intervention) and 5 months (3-month post intervention)

次要结局

  • depression (measured by the Patient Health Questionnaire-9, PHQ-9)(At baseline, 2 months (immediately after intervention) and 5 months (3-month post intervention))
  • anxiety (the General Anxiety Disorder-7, GAD-7)(At baseline, 2 months (immediately after intervention) and 5 months (3-month post intervention))
  • mindfulness level (the 20-item Five Facet Mindfulness Questionnaire, FFMQ)(At baseline, 2 months (immediately after intervention) and 5 months (3-month post intervention))
  • health service utilization(At baseline, 2 months (immediately after intervention) and 5 months (3-month post intervention))
  • health related quality of life (the EQ-5D-5L)(At baseline, 2 months (immediately after intervention) and 5 months (3-month post intervention))

研究者

发起方
Health and Medical Research Fund, Food and Health Bureau, HKSAR

研究点 (1)

Loading locations...

相似试验